| Authors | Morgan S, Hurley J |
|---|
| Source | Canadian Medical Association Journal [Synopsis]. 2004 March 16;170(6):945-946. |
|---|
| Abstract | Enter the name of a popular prescription drug in an Internet search engine and you will quickly grasp just how big the Internet pharmacy market is in Canada. A large proportion of sales are to US customers, who are estimated to purchase upward of US$1 billion in drugs per year from Canadian pharmacies. Americans are turning to Canadian pharmacies with good reason: for many of them, Canadian retail prices for brand-name prescription drugs are a bargain. But, even in this era of free trade and regulatory harmonization, many American policy-makers are opposed to such bargain hunting. Although their opposition generally revolves around a purported concern with public safety, the underlying objections are clearly rooted in protecting the industry's profitability. In doing so, policy-makers are supporting pricing strategies that ultimately harm uninsured and underinsured Americans. |
|---|
| Code | CHSPR 04:05R |
|---|